Literature DB >> 12780700

Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression.

F Conti1, M Sorice, A Circella, C Alessandri, V Pittoni, B Caronti, C Calderaro, T Griggi, R Misasi, G Valesini.   

Abstract

It is well known that monocytes may play an active role in thrombogenesis, since they may express on their surface tissue factor, the major initiator of the clotting cascade. The results of this investigation demonstrate beta-2-glycoprotein I (beta2-GPI) mRNA expression by human peripheral blood monocytes, indicating that these cells synthesize beta2-GPI. In addition, we show beta2-GPI expression on cell surface of these cells by flow cytometric analysis, and the presence of this protein in cell lysate by Western blot. Interestingly, beta2-GPI expression on monocytes is significantly increased in patients with anti-phospholipid syndrome (APS) or systemic lupus erythematosus (SLE) as against healthy blood donors and correlates with tissue factor expression on monocytes. These findings support the view that monocytes are able to synthesize beta2-GPI and suggest that patients with APS may have increased beta2-GPI exposure on cell surface, which leads to persistently high monocyte tissue factor expression and consequently to a prothrombotic diathesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780700      PMCID: PMC1808726          DOI: 10.1046/j.1365-2249.2003.02180.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Synthesis of beta2 glycoprotein 1 by the human placenta.

Authors:  L W Chamley; J L Allen; P M Johnson
Journal:  Placenta       Date:  1997 Jul-Aug       Impact factor: 3.481

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome.

Authors:  P M Dobado-Berrios; C López-Pedrera; F Velasco; M A Aguirre; A Torres; M J Cuadrado
Journal:  Thromb Haemost       Date:  1999-12       Impact factor: 5.249

4.  Anti-beta 2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells.

Authors:  A Kornberg; Y Renaudineau; M Blank; P Youinou; Y Shoenfeld
Journal:  Isr Med Assoc J       Date:  2000-07       Impact factor: 0.892

5.  Evidence for anticoagulant activity and beta2-GPI accumulation in late endosomes of endothelial cells induced by anti-LBPA antibodies.

Authors:  M Sorice; D Ferro; R Misasi; V Pittoni; A Longo; A Circella; T Garofalo; R Gradini; F Violi; J Gruenberg; G Valesini
Journal:  Thromb Haemost       Date:  2002-04       Impact factor: 5.249

6.  Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA.

Authors:  P Ponte; S Y Ng; J Engel; P Gunning; L Kedes
Journal:  Nucleic Acids Res       Date:  1984-02-10       Impact factor: 16.971

7.  The anticardiolipin syndrome.

Authors:  G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1985 Oct-Dec       Impact factor: 4.473

8.  Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells.

Authors:  S Dunoyer-Geindre; E K Kruithof; B Galve-de Rochemonteix; C Rosnoblet; J Gruenberg; G Reber; P de Moerloose
Journal:  Thromb Haemost       Date:  2001-05       Impact factor: 5.249

9.  Monocyte tissue factor induction by activation of beta 2-glycoprotein-I-specific T lymphocytes is associated with thrombosis and fetal loss in patients with antiphospholipid antibodies.

Authors:  S Visvanathan; C L Geczy; J A Harmer; H P McNeil
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

10.  Genetic variation in apolipoprotein H (beta2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus.

Authors:  M I Kamboh; S Manzi; H Mehdi; S Fitzgerald; D K Sanghera; L H Kuller; C E Atson
Journal:  Lupus       Date:  1999       Impact factor: 2.911

View more
  12 in total

Review 1.  Antiphospholipid syndrome: multiple mechanisms.

Authors:  C G Mackworth-Young
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 2.  Antiphospholipid syndrome: an update for clinicians and scientists.

Authors:  Andrew P Vreede; Paula L Bockenstedt; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

3.  Increased Adhesive Potential of Antiphospholipid Syndrome Neutrophils Mediated by β2 Integrin Mac-1.

Authors:  Gautam Sule; William J Kelley; Kelsey Gockman; Srilakshmi Yalavarthi; Andrew P Vreede; Alison L Banka; Paula L Bockenstedt; Omolola Eniola-Adefeso; Jason S Knight
Journal:  Arthritis Rheumatol       Date:  2020-01       Impact factor: 10.995

4.  Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target.

Authors:  Jason S Knight; He Meng; Patrick Coit; Srilakshmi Yalavarthi; Gautam Sule; Alex A Gandhi; Robert C Grenn; Levi F Mazza; Ramadan A Ali; Paul Renauer; Jonathan D Wren; Paula L Bockenstedt; Hui Wang; Daniel T Eitzman; Amr H Sawalha
Journal:  JCI Insight       Date:  2017-09-21

5.  Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.

Authors:  Srilakshmi Yalavarthi; Travis J Gould; Ashish N Rao; Levi F Mazza; Alexandra E Morris; Carlos Núñez-Álvarez; Diego Hernández-Ramírez; Paula L Bockenstedt; Patricia C Liaw; Antonio R Cabral; Jason S Knight
Journal:  Arthritis Rheumatol       Date:  2015-11       Impact factor: 10.995

6.  Combined detection of anticardiolipin and anti-β2-glycoprotein 1 antibodies may predict pregnancy outcome.

Authors:  Rongjuan Yang; Jiajia Zhang; Limei Zhang; Yongli Liu; Qing Guo
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

7.  The NF-κB specific inhibitor DHMEQ prevents thrombus formation in a mouse model of antiphospholipid syndrome.

Authors:  Misato Nishimura; Tokiko Nii; Gulzhan Trimova; Shuhei Miura; Kazuo Umezawa; Akira Ushiyama; Tetsuo Kubota
Journal:  J Nephropathol       Date:  2013-04-01

Review 8.  Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome.

Authors:  Juan J Fierro; Manuela Velásquez; Angela P Cadavid; Karina de Leeuw
Journal:  Am J Reprod Immunol       Date:  2021-12-04       Impact factor: 3.777

9.  Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome.

Authors:  Ramadan A Ali; Alex A Gandhi; He Meng; Srilakshmi Yalavarthi; Andrew P Vreede; Shanea K Estes; Olivia R Palmer; Paula L Bockenstedt; David J Pinsky; Joan M Greve; Jose A Diaz; Yogendra Kanthi; Jason S Knight
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

Review 10.  Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance.

Authors:  Cristiano Alessandri; Michele Bombardieri; Guido Valesini
Journal:  Adv Clin Chem       Date:  2006       Impact factor: 5.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.